# Gemcitabine With or Without Capecitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

> **NCT00032175** · PHASE3 · COMPLETED · sponsor: **Cancer Research UK** · enrollment: 508 (estimated)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **DRUG:** capecitabine
- **DRUG:** gemcitabine hydrochloride

## Key facts

- **NCT ID:** NCT00032175
- **Lead sponsor:** Cancer Research UK
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-04
- **Primary completion:** —
- **Final completion:** 2007-05
- **Target enrollment:** 508 (ESTIMATED)
- **Last updated:** 2013-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00032175

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00032175, "Gemcitabine With or Without Capecitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00032175. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*